Cyclobenzaprine in Brief
- Active ingredient: Cyclobenzaprine hydrochloride
- Brand names: Flexeril, Fexmid
- Drug class: Skeletal Muscle Relaxant
- FDA Approved: August 26, 1977
- Pregnancy Category: B
- Habit forming? No
- Originally discovered: 1961, Merck and Co, USA
Cyclobenzaprine hcl is a long-acting
skeletal muscle relaxant which
relieves muscle spasms and improves signs and symptoms such as pain,
tenderness, limitation of motion, and restriction in activities of daily
living. It is closely related to the first-generation tricyclic
The principal side effects of cyclobenzaprine are drowsiness, dry mouth
or tongue, dizziness and bad taste.
Cyclobenzaprine after its synthesis in 1961 was found to have limited
antidepressant action with no significant advantage over other tricyclics.
However it was found to act as a centrally acting muscle
relaxant and has been widely used ever since.
Cyclobenzaprine was approved by the U.S. Food and Drug Administration
in 1977 for the treatment of acute muscle spasms of local origin. Cyclobenzaprine
is sold as a hydrochloride salt in a 10 mg non-scored tablet under the
trade name Flexeril (Merck and Co.) or as a generic (Genera, Warner-Chilcott,
Duramed, Mylan, Endogenerics, and Watson).
Once-a-day extended release formulation, Amrix, has been approved by
the FDA in 2007 and is available in 15 and 30 mg capsules.
FDA approved uses
- adjunct to rest and physical therapy for relief of muscle spasm
associated with acute, painful musculoskeletal conditions
A muscle spasm is an uncontrollable contraction of a muscle. Cyclobenzaprine
only works to relieve muscle spasms caused by problems in the muscles. It
is ineffective in muscle spasm due to central nervous system disease.
levator ani syndrome
Off-label & Investigational uses
- Fibromyalgia1, 3
Cyclobenzaprine may be helpful for sleep and pain control in fibromyalgia.
The usual starting dose is 5-10 mg taken at bedtime. The dose may
be increased to 20-30 mg, taken either at night or in divided doses
during the day. Compared with amitriptyline, cyclobenzaprine is associated
with better patient acceptance due to fewer side effects and more
rapid onset of relief.
Cyclobenzaprine has been studied in the treatment of fibromyalgia.
In a study of 120 fibromyalgia patients, those receiving Cyclobenzaprine
(10 to 40 mg) over a 12 week period had significantly improved quality
of sleep and pain score. Interestingly, there was also a reduction
in the total number of tender points and muscle tightness.
A meta-analysis of cyclobenzaprine showed that it was superior to
placebo for treating fibromyalgia but that it was not as effective
- Tension headaches2
In a 1972 double-blind study, 10 of 20 patients receiving cyclobenzaprine
experienced a 50% or greater improvement in tension-type headache,
compared with only 5 of 20 patients receiving placebo. The usual dose
of cyclobenzaprine is 10 mg at bedtime.
- Levator ani syndrome
- Tinnitus 4
Cyclobenzaprine may attenuate some forms of tinnitus, e.g. noise-induced tinnitus.
Cyclobenzaprine "pros" and "cons"
- Effective. Quick and lasting symptoms relief (back pain,
neck pain, muscle spasms)
- No potential for abuse and dependence.
- May be useful in patients with insomnia because of severe muscle
- Pregnancy category B. Cyclobenzaprine is considered to be
safe during pregnancy.
- Sedation. Commonly causes drowsiness and
dizziness, which may interfere with your daily activity. Even if you
take cyclobenzaprine just at bedtime, you may experience a hangover-like
effect in the morning.
- Life-threatening interactions with MAO
- Toxic potential similar to tricyclic antidepressants. Cyclobenzaprine
shares the toxic potentials of the tricyclic antidepressants, including
prolongation of conduction time, arrhythmias, and tachycardia.
Mode of action
Onset of action: 1 h.
Duration of action: 12 to 24 h.
Cyclobenzaprine is a muscle relaxant acting primarily on the central nervous system. It is structurally similar
to amitriptyline, differing
by only one double bond. Cyclobenzaprine is a weak inhibitor of presynaptic
norepinephrine and serotonin. Skeletal muscle relaxant activity is due
to brainstem mediated inhibition of gamma motor neurons.
Time for Cyclobenzaprine to clear out the system
Cyclobenzaprine is eliminated quite slowly, with an effective half-life
of 18 hours. It usually takes 4-5 days to leave the system.
- 1. See S, Ginzburg R. Choosing a skeletal
muscle relaxant. Am Fam Physician. 2008 Aug 1;78(3):365-70.
- 2. Lance JW, Anthony M. Cyclobenzaprine
in the treatment of chronic tension headache. Med J Aust. 1972 Dec
- 3. Moldofsky H. Management of sleep disorders
in fibromyalgia. Rheum Dis Clin North Am. 2002 May;28(2):353-65. PubMed
- 4. Vanneste S, Figueiredo R, De Ridder D. Treatment of tinnitus with cyclobenzaprine: an open-label study. Int J Clin Pharmacol Ther. 2012 May;50(5):338-44. PubMed
Published: October 05, 2008
Last updated: October 18, 2013